Discordance between the erythrocyte sedimentation rate and C-reactive protein in rheumatic diseases: reported frequencies, patterns, and clinical interpretation

The erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are routinely ordered together, yet the evidence on how to interpret the two results when they disagree has not been synthesised by disease and by the layer at which the two markers are compared. Seventy studies are included in this review and grouped along those two axes: as raw laboratory values, as the ESR- and CRP-based versions of a composite disease-activity index, or as a ratio. Every reported figure is presented with a definition and cut-off value behind it, after which the reported causes of separation are set out, together with the analytical methods each study reported. The evidence is summarised from three angles. On reported frequencies, discordance and dual-normal results are both common, but the reported frequencies cannot be pooled: Those values depend on how each study defined discordance and on whom it studied, with one laboratory obtaining 6.4%–27% from the same patients under three definitions. On composite indices, the ESR- and CRP-based versions are not freely interchangeable, and how far they diverge depends on which index it is: the 28-joint Disease Activity Score (DAS28) calculated with the ESR (DAS28-ESR) reads consistently higher than DAS28-CRP, the Ankylosing Spondylitis Disease Activity Score (ASDAS) shows no consistent direction, and the Juvenile Arthritis Disease Activity Score (JADAS) and the polymyalgia rheumatica activity score agree closely. On dual-normal results, normal values in both tests do not exclude active disease: Both were normal in 58.0% of patients with clinically active rheumatoid arthritis and in 4%–10% of biopsy-proven giant cell arteritis. The first two angles concern conventions of measurement and can be corrected by reporting discipline; the third is a biological limitation, since inflammation can be present without a systemic acute-phase response large enough to raise either marker above its reference limit, and reporting cannot remove it. A normal CRP does not exclude infection either. The ESR method went unreported in 40 of the 64 studies that measured it, and only one stated how long the sample waited before analysis. Empty cells are reported as empty, not inferred.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-11-12
DOI
https://doi.org/10.3389/fmed.2026.2005901
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Discordance between the erythrocyte sedimentation rate and C-reactive protein in rheumatic diseases: reported frequencies, patterns, and clinical interpretation

Sha Huang, Tingting Luo, Yan Liu, Xia Li et al.
Frontiers in Medicine
Rheumatoid Arthritis Research and Therapies
article

Discordance between the erythrocyte sedimentation rate and C-reactive protein in rheumatic diseases: reported frequencies, patterns, and clinical interpretation

Sha Huang, Tingting Luo, Yan Liu, Xia Li, Xing Pan, Wenqing Zhang
article en

Abstract

The erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are routinely ordered together, yet the evidence on how to interpret the two results when they disagree has not been synthesised by disease and by the layer at which the two markers are compared. Seventy studies are included in this review and grouped along those two axes: as raw laboratory values, as the ESR- and CRP-based versions of a composite disease-activity index, or as a ratio. Every reported figure is presented with a definition and cut-off value behind it, after which the reported causes of separation are set out, together with the analytical methods each study reported. The evidence is summarised from three angles. On reported frequencies, discordance and dual-normal results are both common, but the reported frequencies cannot be pooled: Those values depend on how each study defined discordance and on whom it studied, with one laboratory obtaining 6.4%–27% from the same patients under three definitions. On composite indices, the ESR- and CRP-based versions are not freely interchangeable, and how far they diverge depends on which index it is: the 28-joint Disease Activity Score (DAS28) calculated with the ESR (DAS28-ESR) reads consistently higher than DAS28-CRP, the Ankylosing Spondylitis Disease Activity Score (ASDAS) shows no consistent direction, and the Juvenile Arthritis Disease Activity Score (JADAS) and the polymyalgia rheumatica activity score agree closely. On dual-normal results, normal values in both tests do not exclude active disease: Both were normal in 58.0% of patients with clinically active rheumatoid arthritis and in 4%–10% of biopsy-proven giant cell arteritis. The first two angles concern conventions of measurement and can be corrected by reporting discipline; the third is a biological limitation, since inflammation can be present without a systemic acute-phase response large enough to raise either marker above its reference limit, and reporting cannot remove it. A normal CRP does not exclude infection either. The ESR method went unreported in 40 of the 64 studies that measured it, and only one stated how long the sample waited before analysis. Empty cells are reported as empty, not inferred.

Frontiers in MedicineVol. 13
Chongqing Dazu District People's Hospital (CN)
Good health and well-being
Rheumatoid Arthritis Research and Therapies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon